Summary
Subcutaneous injection of epidermal growth factor 1. significantly shortened the latency period for the appearance of methylcholanthrene induced skin tumors and 2. increased the average number of papillomas elicited per mouse in both the Swiss Webster and C3HeB/FeJ strains.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literatur
J. Furth, Fedn. Proc.20, 865 (1961).
H. T. Deelman, Br. med. J.1, 872 (1927).
H. Hennings andR. K. Boutwell, Cancer Res.30, 312 (1970).
J. M. Twort andC. C. Twort, Am. J. Cancer35, 80 (1939).
J. V. Frei andP. Stephens, Br. J. Cancer22, 83 (1968).
W. F. Friedwald andP. Rous, J. exp. Med.80, 101 (1944).
S. Cohen andG. A. Elliott, J. Invest. Dermat.40, 1 (1963).
S. Cohen, Devel. Biol.12, 394 (1965).
R. W. Turkington, Expl Cell Res.57, 79 (1969).
R. W. Turkington, Cancer Res.29, 1457 (1969).
B. L. Van Duuren andL. Orris, Cancer Res.25, 1871 (1965).
A. Sivak, J. cell. Physiol.80, 167 (1972).
S. P. Rose, R. M. Pruss andH. R. Herschman, J. cell. Physiol.86, 593 (1975).
V. H. Reynolds, F. H. Boehm andS. Cohen, Surgical Forum16, 108 (1965).
F. Wilcoxon andR. A. Wilcox,Some Rapid Approximate Statistical Procedures (Lederle Labs., Pearl River, New York 1964), p. 7.
S. Cohen andR. Savage, inRecent Progress in Hormone Research (Ed.R. O. Greep, Academic Press, New York 1974), p. 572.
Author information
Authors and Affiliations
Additional information
Acknowledgments. This research was supported by USPHS NCI Grant No. CA 15276 and Contract No. GEN-12 between the Regents of the University of California and the U.S. Energy Research and Development Administration. We thankIlmar Lepik for his assistance in some phases of these experiments.
Rights and permissions
About this article
Cite this article
Rose, S.P., Stahn, R., Passovoy, D.S. et al. Epidermal growth factor enhancement of skin tumor induction in mice. Experientia 32, 913–915 (1976). https://doi.org/10.1007/BF02003764
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02003764